A novel de novo splicing mutation of STXBP1 in epileptic encephalopathy associated with hypomyelinating leukodystrophy
Author:
Wang Zixuan1, Zhang Jun1, Zhou Yunfei1, Wang Juan1, Liu Guicen1, Tian Zixin1
Affiliation:
1. Chongqing Medical University
Abstract
Abstract
Background: Deleterious variations in STXBP1 are responsible for early infantile epileptic encephalopathy type 4 (EIEE4, OMIM # 612164) because of its dysfunction in the central nervous system. The clinical spectrum of the neurodevelopmental delays associated with STXBP1 aberrations is collectively defined as STXBP1 encephalopathy (STXBP1-E), the conspicuous features of which are highlighted by early-onset epileptic seizures without structural brain anomalies. The girl first diagnosed with the unexplained disorders of movement and cognitive later was developed into STXBP1-E with unexpected leukoaraiosis and late-onset of seizures.
Methods: The genetic screening and molecular tricks including trio Whole Exome Sequencing (WES), Sanger sequencing, bioengineering with CRISPR/Cas9, Western blot, qPCR/RT-PCR and bioinformatic analyses alongside neurological examinations were employed to investigate the genetic etiology and established the diagnosis.
Results: A novel de novo heterozygous mutation of c.37+2dupT at STXBP1 splice site was identified as the pathogenic cause in the affected girl. The de novo mutation (DNM) didn't result in any truncated proteins, but immediately trigger mRNA degradation by nonsense-mediated mRNA decay (NMD), which led to the haploinsufficiency of STXBP1. The patient showed the atypical phenotypes characterized by hypomyelinating leukodystrophy and late-onset of epileptic seizures, which had never previously been delineated in STXBP1-E.
Conclusion: The findings strongly implicated that the haploinsufficiency of STXBP1 could also exhibit divergent clinical phenotypes because of the genetic heterogeneity in the subset of encephalopathies.
Publisher
Research Square Platform LLC
Reference24 articles.
1. Jahn R, Fasshauer D. Molecular machines governing exocytosis of synaptic vesicles. Nature. 2012 Oct 11;490(7419):201-7. https://doi:10.1038/nature11320. 2. Role of Munc18-1 in the biological functions and pathogenesis of neurological disorders;Tang F;Mol Med Rep,2021 3. Reconstitution of the vital functions of Munc18 and Munc13 in neurotransmitter release;Ma C;Science. 2013 Jan 4. Stamberger H, Nikanorova M, Willemsen MH, Accorsi P, Angriman M, Baier H, Benkel-Herrenbrueck I, Benoit V, Budetta M, Caliebe A, Cantalupo G, Capovilla G, Casara G, Courage C, Deprez M, Destrée A, Dilena R, Erasmus CE, Fannemel M, Fjær R, Giordano L, Helbig KL, Heyne HO, Klepper J, Kluger GJ, Lederer D, Lodi M, Maier O, Merkenschlager A, Michelberger N, Minetti C, Muhle H, Phalin J, Ramsey K, Romeo A, Schallner J, Schanze I, Shinawi M, Sleegers K, Sterbova K, Syrbe S, Traverso M, Tzschach A, Uldall P, Van Coster R, Verhelst H, Viri M, Winter S, Wolff M, Zenker M, Zoccante L, De Jonghe P, Helbig I, Striano P, Lemke JR, Møller RS, Weckhuysen S. STXBP1 encephalopathy: A neurodevelopmental disorder including epilepsy. Neurology. 2016 Mar 8;86(10):954 – 62. https://doi:10.1212/WNL.0000000000002457. 5. Khaikin Y, Mercimek-Andrews S.2016 Dec 1. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. STXBP1 Encephalopathy with Epilepsy. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. https://www.ncbi.nlm.nih.gov/books/NBK396561/
|
|